• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE PROA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE PROA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1128350-38
Device Problems Deflation Problem (1149); Failure to Fold (1255); Difficult to Remove (1528); Material Too Rigid or Stiff (1544)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/02/2021
Event Type  malfunction  
Manufacturer Narrative
The device is expected to be returned for evaluation.It has not yet been received.A follow-up report will be submitted with all additional relevant information.The additional device referenced in is being filed under a separate medwatch report number.The xience proa device is currently not commercially available in the us; however, it is similar to a device sold in the us.
 
Event Description
It was reported the that procedure was to treat a mildly calcified proximal and distal right coronary artery.The 3.5x38mm xience proa was implanted distally followed by the 4.0x12mm xience proa stent that was implanted proximally.It was noted post deployment the balloon for both stent delivery systems were extremely slow to deflate; however, the devices did fully deflate.Resistance was met during removal with the unspecified guiding catheter.Additionally, the material of the balloon was observed to be too stiff and probably did not refold properly for both stent delivery systems.There was no adverse patient effects reported and no clinically significant delay reported.No additional information was provided.
 
Manufacturer Narrative
The device was returned for analysis.The reported failure to fold (refold) issue was confirmed.The reported deflation issue was not confirmed.The reported difficulty to remove could not be confirmed due to the condition the device was returned for analysis.The reported material too rigid or stiff could not be replicated in a testing environment as it was related to operational context.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.The investigation was unable to determine a conclusive cause for the reported deflation problem as the device deflated without issue or delay during return evaluation; however, factors that may contribute to deflation problems include, but are not limited to, patient anatomical morphology, patient disease state, deflation technique, contrast dilution, and inadequate connection to the deflation device.The reported difficult to remove appears to be related to operational context as resistance during retraction due to interaction with the guiding catheter likely caused the reported difficulty to remove.The interaction with the guiding catheter during retraction may have contributed to the reported refold issues and reported irregular appearance of the device (material too rigid or stiff); however, this cannot be confirmed based on the information provided.Factors that may contribute to non-uniform balloon refold and irregular appearance of the device (material too rigid or stiff) include, but are not limited to, large balloon profile, deflation technique or balloon material properties.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE PROA EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key12342222
MDR Text Key267261294
Report Number2024168-2021-07304
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 10/05/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/19/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/06/2023
Device Catalogue Number1128350-38
Device Lot Number0033041
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/02/2021
Date Manufacturer Received09/21/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age62 YR
Patient Weight125
-
-